13F Holdings
中文EN

Aisling Capital Management LP

NEW YORK NY · SEC CIK 0001766721

2026Q22026Q1 9 earlier quarters 🔒
$471.62M2026Q2 reported value
14Positions
99.0%Top 10 weight · largest 72.5%
1 / 0New / sold out
Reported value over time$471.62M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

BBIO 72.5%
GLUE 8.0%
SNDX 6.1%
CMPS 4.3%
BCAX 3.6%
BBOT 1.6%
SRRK 0.9%
URGN 0.8%
BIOMEA FUSION 0.6%
ACRS 0.5%

2026Q2 top buys estimated at quarter-end value

VTV THERAPEUTICS New+$1.88M

2026Q2 top sells estimated at quarter-end value

BBIO Reduced-$37.24M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
BBIO BRIDGEBIO PHARMA INC $341.83M72.48%4,589,611 -500,000-9.8% -$37.24M Reduced
GLUE MONTE ROSA THERAPEUTICS INC $37.65M7.98%1,555,664 00.0% — Unchanged
SNDX SYNDAX PHARMACEUTICALS INC $28.79M6.10%1,316,806 00.0% — Unchanged
CMPS COMPASS PATHWAYS PLC $20.27M4.30%1,432,336 00.0% — Unchanged
BCAX BICARA THERAPEUTICS INC $16.89M3.58%568,919 00.0% — Unchanged
BBOT BRIDGEBIO ONCOLOGY THERAPEUT $7.76M1.64%1,018,018 00.0% — Unchanged
SRRK SCHOLAR ROCK HLDG CORP $4.24M0.90%77,031 00.0% — Unchanged
URGN UROGEN PHARMA LTD $3.97M0.84%108,000 00.0% — Unchanged
— BIOMEA FUSION INC $3.01M0.64%2,048,757 00.0% — Unchanged
ACRS ACLARIS THERAPEUTICS INC $2.30M0.49%434,455 00.0% — Unchanged
EPRX EUPRAXIA PHARMACEUTICALS INC $2.15M0.46%325,000 00.0% — Unchanged
— VTV THERAPEUTICS INC $1.88M0.40%50,000 50,000— $1.88M New
— MARKER THERAPEUTICS INC $478,2930.10%325,370 00.0% — Unchanged
OKUR ONKURE THERAPEUTICS INC $404,0480.09%88,607 00.0% — Unchanged